California Policy Makers Join Stroll Health to Discuss the Future of Affordable Healthcare
Today, Jordan Epstein, CEO of Stroll Health, met with a delegation of policy makers led by Senator Jerry Hill and Assemblymember Kevin Mullin to discuss the future of affordable healthcare. Along with leaders from Amgen, Johnson & Johnson, and Gilead, Mr. Epstein joined round-table discussions on crafting policies that will facilitate the development of new technology, control healthcare costs, and improve access to care. The representatives visited a number of leading digital health and biotech companies as part of their “Health Care Innovation Tour” through the Silicon Valley.
About Stroll Health:
Large integrated systems and advanced independent practices trust Stroll to provide a tailored patient experience that improves compliance and access to quality care. With an intelligent value-based referral system, including insurance verification, automated prior authorizations, real-time scheduling, out-of-pocket cost estimates, and effective patient reminders, Stroll saves time for providers and patients and drives meaningful, measurable improvement in both volume and value-based revenue. Stroll’s research into better value care delivery is supported by grants from Robert Wood John Foundation and Stanford University, among others. Stroll Health is based in San Francisco, California.